Decoding LRCX Stock’s Premium Valuation

LRCX: Lam Research logo
LRCX
Lam Research

At $388.92, Lam Research (LRCX) is being priced to deliver 26.0% revenue growth annually for the next 5 years simply to defend today’s 72.5x multiple. That is essentially the 26.5% the business is already running, held steady through 5 more years. Sounds easy until it stops.

Lam Research is in an AI-fueled acceleration phase. The company provides critical deposition and etch equipment to the world’s largest semiconductor makers.

This demand is pulling major customer technology conversions forward at an intense pace. To meet the surge, management is increasing R&D investments while bringing a second manufacturing facility in Malaysia online.

With that as the operational backdrop, the question is whether 26.0% revenue growth for 5 years is reasonable for LRCX. Before we walk through how the math gets to that number, here are LRCX’s current numbers as a reference point:

Relevant Articles
  1. Is Micron Stock’s Data Center Engine Stalling, Or Just Drowned Out By AI?
  2. How Steep Is the Plunge for Gildan Stock?
  3. MACOM Technology Solutions Stock Is Down, But Its Business Is Looking Up. What Gives?
  4. Is the Pullback in Sanmina Stock a Glitch or a Warning?
  5. MU, NVDA Look Smarter Buy Than ON Semiconductor Stock
  6. Strong Cash Yield: Is Ulta Beauty Stock A Buy?

LRCX
Sector Information Technology
Industry Semiconductor Materials & Equipment
P/E Ratio 72.5
P/E Ratio 3Y Avg 27.8
LTM Revenue Growth 26.5%
3Y Avg Revenue Growth 7.5%
LTM Net Margin 30.9%
3Y Peak Net Margin 30.9%
3Y Avg Net Margin 27.0%

LTM refers to last twelve months.

Trefis: LRCX Stock Insights

For the full historical trajectory of these lines, see LRCX’s data page.

Where That 26.0% Comes From

First, we give the business 5 years to grow into the multiple. Second, we assume the P/E settles at 24.3x at maturity, where mature, leading-edge semiconductor businesses typically clear. Third, margins land near 29.0%, anchored on the company’s own track record, which already runs at or above what mature peers earn.

With those locked in, the mechanical arithmetic takes over. LRCX’s $486.0B market cap divided by 24.3x implies $20.0B of net income at maturity. At a 29.0% margin, that requires $69.0B of revenue, up from $21.7B today. Compounded over 5 years, that lands on the 26.0% annual growth the lead opened with.

Can LRCX Pull That Off?

Growth is being driven by specific technology shifts, with advanced packaging revenue expanding rapidly. The company’s large installed base is also a strength, as its Customer Support Business Group just delivered a record quarter.

The current boom is occurring within a historically cyclical industry. A key indicator of this risk is that customer down payments have fallen to their lowest level in years, while revenue from China is expected to decline.

On the surface you are paying for continuity. But the current pace is a cyclical peak, not a sustainable rate. In a normal year, the bar is meaningfully higher than the lead suggests.

Buyback tailwind: LRCX has retired roughly 7.4% of share count over three years. The per-share math is easier than the absolute math.

Lam is capitalizing on an AI equipment super-cycle, but slowing customer prepayments signal a potential cyclical turn ahead.

Should You Invest In Lam Research?

Reverse-engineering the growth baked into today’s high multiples reveals a thin margin for error. A single-stock thesis at these valuations is inherently fragile. As historical volatility shows, relying on the priced-for-perfection math of one position ignores the structural risk that high-multiple names face during broader market inflections. The solution is a rule-based portfolio approach.

The Trefis High Quality (HQ) Portfolio combines analytical rigor with a forward-looking view across 30 stocks, with a consistent selection framework and sizing/re-balancing discipline designed to deliver upside without the single-name risk you just read through here.

By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000.